Bald and beautiful, this unique-looking cat is one of the rarest felines around—find out if the friendly, outgoing, and ...

J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.

Molecular profiling could reduce both overtreatment and undertreatment of patients with high-intermediate risk endometrial ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced data from a colorectal ...

Fibrolamellar hepatocellular carcinoma (FLC) has no approved treatment and occurs mostly in adolescents and young adults - KUALA LUMPUR, Malaysia, July 07, 2025 (GLOBE NEWSWIRE) -- Cyclacel ...

CRISPR technology is transforming modern medicine by enabling precise DNA editing to treat genetic disorders, including sickle cell anemia and beta-thalassemia, experts say.

J&J has rights to niraparib in prostate cancer, and views the drug as a successor to Zytiga, once a $2.5 billion-a-year ...

News reports, trends, analysis and Daily Updates on Business, Technology, Startups, Science, and Innovation in India and ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...

When the Covid-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people - but in the background there was ...